BiotechTube
Home/Neuren Pharmaceuticals/Patrick Davies
PD

Patrick Davies

Non-Executive Chair

Neuren Pharmaceuticals

Therapeutic Areas

Neurodevelopmental DisordersNeurodegenerative Disorders

Neuren Pharmaceuticals Pipeline

DrugIndicationPhase
DAYBUE® (trofinetide)Rett SyndromeApproved
NNZ-2591Phelan-McDermid SyndromePhase 2

Leadership Team at Neuren Pharmaceuticals

JP
Jon Pilcher
Chief Executive Officer/Managing Director
DA
Dianne Angus
Non-Executive Director
View full Neuren Pharmaceuticals profile